CCL18 - Potential biomarker of fibroinflammatory activity in chronic periaortitis

Journal of Rheumatology

Volumn 39, Issue 7, 2012, Pages 1407-1412

  Kollert, Florian ^a   Binder, Moritz ^a   Probst, Corina ^a   Uhl, Markus ^a   Zirlik, Andreas ^a   Kayser, Gian ^a   Voll, Reinhard E ^a   Peter, Hans Hartmut ^a   Zissel, Gernot ^a   Prasse, Antje ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Biomarker; CCL18; Chronic periaortitis; Ormond's disease; Retroperitoneal fibrosis

Indexed keywords

BIOLOGICAL MARKER; CC CHEMOKINE LIGAND 18; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA; AORTA ATHEROSCLEROSIS; AORTITIS; ARTICLE; CHRONIC PERIAORTITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; LABORATORY TEST; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINES, CC; CREATININE; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84863522484     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111143     Document Type: Article

References (35)

1. Mitchinson MJ. Chronic periaortitis and periarteritis. Histopathology 1984;8:589-600. (Pubitemid 14063068)
2. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990;114:383-7. (Pubitemid 20135843)
3. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: A large-vessel vasculitis? Curr Opin Rheumatol 2011;23:1-6.
4. Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C. Retroperitoneal fibrosis: Evolving concepts. Rheum Dis Clin North Am 2007;33:803-17. (Pubitemid 350130314)
5. Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, et al. Chronic periaortitis and HLA-DRB1*03: Another clue to an autoimmune origin. Arthritis Rheum 2006;55:126-30. (Pubitemid 43235137)
6. Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C. Evidence of autoimmunity in chronic periaortitis: A prospective study. Am J Med. 2003;114:454-62. (Pubitemid 36515107)
7. Swartz RD. Idiopathic retroperitoneal fibrosis: A review of the pathogenesis and approaches to treatment. Am J Kidney Dis 2009;54:546-53.
8. Warnatz K, Keskin AG, Uhl M, Scholz C, Katzenwadel A, Vaith P, et al. Immunosuppressive treatment of chronic periaortitis: A retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005;64:828-33. (Pubitemid 40733903)
9. Wagenknecht LV, Hardy JC. Value of various treatments for retroperitoneal fibrosis. Eur Urol 1981;7:193-200. (Pubitemid 11126325)
10. Marcolongo R, Tavolini IM, Laveder F, Busa M, Noventa F, Bassi P, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: A retrospective analysis of 26 cases. Am J Med 2004;116:194-7. (Pubitemid 38121678)
11. Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA. Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 1994;28:237-42. (Pubitemid 24297343)
12. Grotz W, von Zedtwitz I, Andre M, Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 1998;352:1195. (Pubitemid 28458541)
13. Khalil F, Mir MA, Venuto RC. Mycophenolate mofetil in the treatment of retroperitoneal fibrosis. Clin Rheumatol 2008;27:679-81.
14. Marzano A, Trapani A, Leone N, Actis GC, Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis 2001;60:427-8. (Pubitemid 32242763)
15. Scavalli AS, Spadaro A, Riccieri V, Ricciuti GP, Taccari E, Marini M, et al. Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol 1995;14:481-4.
16. Vega J, Goecke H, Tapia H, Labarca E, Santamarina M, Martínez G. Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: A case series. Am J Kidney Dis 2009;53:628-37.
17. de Socio G, Verrecchia E, Fonnesu C, Giovinale M, Gasbarrini GB, Manna R. Effectiveness of colchicine therapy in 4 cases of retroperitoneal fibrosis associated with autoinflammatory diseases. J Rheumatol 2010;37:1971-2.
18. van Bommel EFH, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 2007;49:615-25. (Pubitemid 46654499)
19. Scheel PJJ, Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: A case series. Ann Intern Med 2011;154:31-6.
20. Scheel PJJ, Piccini J, Rahman MH, Lawler L, Jarrett T. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol 2007;178:140-3.
21. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: Report and characterisation of a new disease. BMC Med 2006;4:23.
22. Zen Y, Nakanuma Y. IgG4-related disease: A cross-sectional study of 114 cases. Am J Surg Pathol 2010;34:1812-9.
23. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4. (Pubitemid 37455786)
24. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:88-94.
25. Binder M, Uhl M, Wiech T, Kollert F, Thiel J, Sass JO, et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: A long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis 2011;2:311-2.
26. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006;173:781-92.
27. Prasse A, Pechkovsky DV, Toews GB, Schäfer M, Eggeling S, Ludwig C, et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 2007;56:1685-93. (Pubitemid 46764100)
28. Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:717-23.
29. Pechkovsky DV, Prasse A, Kollert F, Engel KMY, Dentler J, Luttmann W, et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 2010;137:89-101.
30. Ahmad S, North BV, Qureshi A, Malik A, Bhangal G, Tarzi RM, et al. CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis. Eur J Clin Invest 2010;40:1067-73.
31. Bellón T, Martínez V, Lucendo B, Del Peso G, Castro MJ, Aroeira LS, et al. Alternative activation of macrophages in human peritoneum: Implications for peritoneal fibrosis. Nephrol Dial Transplant 2011;0:1-10.
32. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, et al. Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis. Kidney Int 2007;72:742-53. (Pubitemid 47373794)
33. Hägg DA, Olson FJ, Kjelldahl J, Jernås M, Thelle DS, Carlsson LMS, et al. Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques. Atherosclerosis 2009;204:e15-20.
34. Kraaijeveld AO, de Jager SCA, de Jager WJ, Prakken BJ, McColl SR, Haspels I, et al. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation 2007;116:1931-41. (Pubitemid 350287089)
35. van Bommel EFH, van Tits LJH, van den Berg EA, Prins J, Stalenhoef AFH. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: Case-control study. Rheumatol Int 2011;31:201-8.